Avalo Therapeutics, Inc. Annual Return On Assets in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Avalo Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2023.
  • Avalo Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -9.06 %, a 91.6% increase year-over-year.
  • Avalo Therapeutics, Inc. annual Return On Assets for 2023 was -114 %, a 12.2% decline from 2022.
  • Avalo Therapeutics, Inc. annual Return On Assets for 2022 was -102 %, a 8.81% increase from 2021.
  • Avalo Therapeutics, Inc. annual Return On Assets for 2021 was -111 %, a 5.16% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -114 -12.4 -12.2% Jan 1, 2023 Dec 31, 2023
2022 -102 +9.81 +8.81% Jan 1, 2022 Dec 31, 2022
2021 -111 +6.06 +5.16% Jan 1, 2021 Dec 31, 2021
2020 -117 -89.2 -316% Jan 1, 2020 Dec 31, 2020
2019 -28.2 +32.2 +53.3% Jan 1, 2019 Dec 31, 2019
2018 -60.4 -119 -203% Jan 1, 2018 Dec 31, 2018
2017 58.9 +204 Jan 1, 2017 Dec 31, 2017
2016 -145 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.